Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Generation of TD50 values for carcinogenicity study dataNovember 2019
Utilising ChEMBL data for building secondary pharmacology modelsOctober 2019pdf fileEffiris
Predictive Toxicology: Using In Silico SystemsOctober 2019pdf fileDerek NexusSarah Nexus
Modelling Simple Toxicity Endpoints: Alerts, (Q)SARs and BeyondMay 2019Derek NexusMeteor NexusSarah NexusVitic Nexus
A Suggested ICH M7 Framework Using Lhasa Limited ProductsMay 2019pdf fileZenethVitic NexusMirabilisSarah NexusDerek Nexus
Development of an Adverse Outcome Pathway (AOP) Network for Carcinogenicity Using Expert-Derived (Q)SAR Knowledge. PosterMarch 2019pdf fileDerek Nexus
How low can you go? An analysis of lowest effective dose in the Ames test.March 2019pdf file
Lhasa's Scientific FutureMarch 2019pdf file
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectOctober 2018Derek NexusSarah Nexus
Extrapolation of in vitro structural alerts for mutagenicity to the in vivo endpointOctober 2018Derek Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
How low can you go? An analysis of lowest effective dose in the Ames test.September 2018pdf fileVitic Nexus
Are all Ames Strains in the OECD Mutagenicity Test Guideline 471 useful and necessary? An analysis of large mutagenicity data sets for the IWGTMay 2018pdf file
Strain profiles: Moving beyond binary Ames classificationMarch 2018pdf fileSarah Nexus
Addressing the Challenge of Making Negative Predictions for Skin SensitisationMarch 2018pdf fileDerek Nexus
Derek Nexus Carcinogenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Chromosome Damage QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Mutagenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Skin Sensitisation QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus HERG QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Teratogenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Understanding Negative Predictions in Derek Nexus - A Detailed WorkflowNovember 2017pdf fileDerek Nexus
Understanding Negative Predictions in Derek NexusNovember 2017pdf fileDerek Nexus
Extrapolation of in vitro mutagenicity alerts to the in vivo endpoint in Derek NexusAugust 2017pdf fileDerek Nexus

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.